Workflow
Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World’s 2nd Largest), Enabling Immediate ART100 Deployment
Globenewswire· 2026-02-09 12:00
RA'ANANA, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN,IINNW) (“Inspira Technologies” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced a pivotal commercial advancement. The Company has received official approval from the Medical Equipment Committee of Clalit Health Services (“Clalit”), recognized as the second-largest integrated Health Maintenance Organization (HMO) globally. The approval enables the INSPIRA ...
Astera Labs Expands Global Footprint with New Israel Design Center to Support Growing Demand for AI Connectivity Solutions
Globenewswire· 2026-02-09 12:00
New design center to focus on cutting-edge AI fabrics and emerging AI inference technologies Industry veteran Guy Azrad to lead operations as general manager of Astera Labs Israel SAN JOSE, Calif. and TEL AVIV, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced a significant expansion of its global engineering operations with the establishment of an advanced research and develop ...
Talisker Intersects 52.2 g/t Au over 0.55 metres, within 19.15 g/t over 1.60 metres, from the 2025 Bralorne Gold Project Resource Conversion Program
Globenewswire· 2026-02-09 12:00
TORONTO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX:TSK | OTCQB:TSKFF) is pleased to announce results from the final 30 drill holes from late 2025, predominantly targeting dip and strike extensions in the major ore veins at its currently producing Mustang Mine. Highlights from the final 30 drill holes include: SB-2025-001 - 30.50 g/t Au over 0.50 m within 10.21 g/t Au over 1.75 m on the 101 VeinSB-2025-001 - 20.70 g/t Au over 0.70 m within 8.75 g/t Au over 1 ...
Ask an Advisor: I'm 47 With $1.87 Million But I'm ‘Burned Out' From My Stressful Career. Can I Retire Early at 51?
Yahoo Finance· 2026-02-09 12:00
(And if you need additional help planning for retirement, consider working with a financial advisor .)Everything that follows from here can, and should, be tweaked depending on your preferences and details we don't have. However, I think this will get you close enough to make a reasonable estimate of how prepared you are to stop working.With all of the information about your assets but none about your lifestyle spending needs, that's analogous to the situation we have here. You've given me a clear picture o ...
Speculative Narrative Unwinds
Seeking Alpha· 2026-02-09 12:00
After having been in the investing world for more than 25 years from private banking and investment management to private and venture capital; I have pretty much "been there and done that" at one point or another. I am currently a partner at RIA Advisors in Houston, Texas. The majority of my time is spent analyzing, researching and writing commentary about investing, investor psychology and macro-views of the markets and the economy. My thoughts are not generally mainstream and are often contrarian in natur ...
Sportradar to Power NBA Fan Experiences Across NBC Sports Regional Sports Networks through Advanced Data and Enhanced Visual Storytelling
Globenewswire· 2026-02-09 12:00
ST GALLEN, Switzerland and NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Sportradar AG (NASDAQ: SRAD) today announced a multi-year agreement with NBC Sports Regional Sports Networks (RSNs) to enhance the NBA viewing experience through real-time, cutting-edge broadcast solutions that enhance live game coverage. NBC Sports Regional Networks will leverage Sportradar’s NBA Advanced Data and GameFrame across live NBA game broadcasts during the 2025-26 and 2026-27 NBA seasons. The agreement supports hundreds of NBA ...
Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update
Globenewswire· 2026-02-09 12:00
– First quarter fiscal 2026 revenue increased 0.8% compared to prior year quarter to $120.9 million – First quarter fiscal 2026 operating loss increased 5.3% compared to prior year quarter to $16.3 million – Conference call scheduled for today at 8:30 am ET WEST LAFAYETTE, Ind., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela ...
Osisko Development Awards Project and Construction Management Services Contract for the Development of the Cariboo Gold Project
Globenewswire· 2026-02-09 12:00
MONTREAL, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") is pleased to announce that its wholly-owned subsidiary, Barkerville Gold Mines Ltd., has entered into a definitive Project and Construction Management Services Agreement with JDS Energy & Mining Inc. ("JDS") for the development of the Cariboo Gold Project, located in British Columbia (the "Cariboo Gold Project"). Sean Roosen, Chairman and CEO, commented, "Formalizing our partn ...
Lilly to acquire Orna Therapeutics to advance cell therapies
Prnewswire· 2026-02-09 12:00
"Early autologous CAR-T studies have shown the promise of cell therapy for patients with autoimmune diseases, but the complexity, cost, and logistics of ex vivo approaches make it challenging to deliver these breakthroughs to the broader population of patients who need them," said Francisco RamÃrez-Valle M.D., Ph.D., Senior Vice President, Head of Immunology Research and Early Clinical Development. "We look forward to working with Orna colleagues to potentially unlock an entirely new class of genetic medici ...
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company's Growth and Execution of Its Mission in Spinal Cord Injury
Globenewswire· 2026-02-09 12:00
VANCOUVER, British Columbia, Feb. 09, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, today announced its Board of Directors has unanimously appointed Adam Rogers, MD, as President and Chief Executive Officer (CEO), effective immediately. Dr. Rogers will continue leading the C ...